These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 180408)

  • 21. Differences in molecular heterogeneity of glucagon-like immunoreactivity in plasma and liver metastases of a patient with alpha-cell tumor.
    Kohnert KD; Kändler C; Woltanski KP; Ziegler M
    Exp Clin Endocrinol; 1985 Feb; 85(1):89-94. PubMed ID: 2985414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Streptozotocin in hormone-active metastasizing islet-cell carcinoma].
    Spech HJ; Wernze H; Brunswig D
    Med Klin; 1973 Apr; 68(17):555-9. PubMed ID: 4350157
    [No Abstract]   [Full Text] [Related]  

  • 23. Glucagon secreting clones of rat islet cell tumor.
    Bhathena SJ; Voyles NR; Oie HK; Smith SS; Gazdar AF; Recant L
    Horm Metab Res; 1980 Nov; 12(11):632-3. PubMed ID: 6257606
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemotherapy of metastatic gastrointestinal neoplasms with 5-fluorouracil and streptozotocin.
    Seligman M; Bukowski RM; Groppe CW; Weick JK; Hewlett JS; Greenstreet RL
    Cancer Treat Rep; 1977 Oct; 61(7):1375-7. PubMed ID: 201379
    [No Abstract]   [Full Text] [Related]  

  • 25. Streptozotocin effective for treating multiple-hormone-producing malignant islet cell tumor.
    Murata E; Tashiro S; Hiraoka T
    Jpn J Surg; 1985 Jan; 15(1):63-7. PubMed ID: 2985854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the liver in glucagon metabolism.
    Jaspan JB; Huen AH; Morley CG; Moossa AR; Rubenstein AH
    J Clin Invest; 1977 Aug; 60(2):421-8. PubMed ID: 874100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diazoxide, encorton and streptozotocin in the treatment of malignant betacytoma.
    Tolloczko T; Wasiutyński A
    Acta Med Pol; 1974; 15(1):69-77. PubMed ID: 4369916
    [No Abstract]   [Full Text] [Related]  

  • 28. [Circulating types of human glucagon (author's transl)].
    Valverde I
    MMW Munch Med Wochenschr; 1978 Mar; 120(12):407-9. PubMed ID: 306029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma proinsulin in patients with functioning pancreatic islet cell tumors.
    Sherman BM; Pek S; Fajans SS; Floyd JC; Conn JW
    J Clin Endocrinol Metab; 1972 Aug; 35(2):271-80. PubMed ID: 4342038
    [No Abstract]   [Full Text] [Related]  

  • 30. Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.
    Kuku SF; Jaspan JB; Emmanouel DS; Zeidler A; Katz AI; Rubenstein AH
    J Clin Invest; 1976 Sep; 58(3):742-50. PubMed ID: 956399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant metastatic insulinoma treated with streptozotocin.
    Gefel A; Flatau E; Ayalon D; Papo J; Loewenthal M
    Clin Endocrinol (Oxf); 1975 Sep; 4(5):461-8. PubMed ID: 170028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Metastatic malignant pancreatic tumor. Disappearance of symptoms 6 months after streptozotocin treatment (author's transl)].
    Simonin R; Bernard PM; Vague P; San Marco JL; Vialettes B
    Ann Endocrinol (Paris); 1973; 34(3):293-4. PubMed ID: 4356380
    [No Abstract]   [Full Text] [Related]  

  • 33. Pancreatic islet cell carcinoma in a dog treated with streptozotocin.
    Meyer DJ
    Am J Vet Res; 1976 Oct; 37(10):1221-3. PubMed ID: 185926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical aspects of glucagon-producing islet cell tumors.
    Prinz RA; Dorsch TR; Lawrence AM
    Am J Gastroenterol; 1981 Aug; 76(2):125-31. PubMed ID: 6272569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vipomas and treatment with streptozotocin: 2 cases].
    Lacroute JM; Sondag D; Baumann R; Abbas A; Schutz JF; Wolff JL; Weill-Bousson M; Weill JP
    Gastroenterol Clin Biol; 1983 Jan; 7(1):14-22. PubMed ID: 6301919
    [No Abstract]   [Full Text] [Related]  

  • 36. Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses.
    Gagel RF; Costanza ME; DeLellis RA; Norton RA; Bloom SR; Miller HH; Ucci A; Nathanson L
    Arch Intern Med; 1976 Dec; 136(12):1429-35. PubMed ID: 187136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Streptozotocin treatment of an insulinoma with hepatic metastases].
    Guilmot JL; Choutet P; Perrotin D; Ginies G; Lamisse F
    Nouv Presse Med; 1979 Oct; 8(38):3055-6. PubMed ID: 230458
    [No Abstract]   [Full Text] [Related]  

  • 38. Streptozotocin treatment of a juvenile onset type diabetic patient with Verner-Morrison syndrome and multi hormonal probable malignant islet cell carcinoma with liver metastases.
    Granuci P; Mahler RJ
    Horm Metab Res; 1982 Jun; 14(6):327-8. PubMed ID: 6288539
    [No Abstract]   [Full Text] [Related]  

  • 39. HCG-alpha and HCG-beta subunits as tumour markers during therapy in a case with so-called "non-functioning" islet cell tumour.
    Oberg K; Wide L; Boström H
    Acta Med Scand; 1981; 210(3):231-3. PubMed ID: 6270988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pattern of immunoreactive glucagon in portal, arterial and peripheral plasma before and after removal of glucagonoma.
    Villar HV; Johnson DG; Lynch PJ; Pond GD; Smith PH
    Am J Surg; 1981 Jan; 141(1):148-52. PubMed ID: 6257127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.